tykhr
sign in
free sign up
Neumora Therapeutics, Inc.
Biotechnology
Healthcare
NMRA
162 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.75
52 week high
16.96
high
1.91
52 week low
0.00
low
1.74
growth
-85.22 %
previous Close
1.73
P/E ratio
market cap
243 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-52.73 M
22.45 %
eps
0.00 %
21.43 %
eps surprise
26.67 %
net profit margin
-5273100000.00 %
0.00 %
operating incoming
-54.04 M
23.82 %
net change in cash
-3.55 M
76.78 %
cash on hand
125 M
-1.84 %
cost of revenue
0.00 %
top